Showing 1 - 13 of 73
View by: Cover Page List Articles
-
Early therapy evaluation of intra-arterial trastuzumab injection in a human breast cancer xenograft model using multiparametric MR imaging
published 03 May 2024
Loading metrics information...
Metrics unavailable. Please check back later.
-
MAF1 is a predictive biomarker in HER2 positive breast cancer
published 06 Oct 2023
Loading metrics information...
Metrics unavailable. Please check back later.
-
HER2 inhibition increases non-muscle myosin IIA to promote tumorigenesis in HER2+ breast cancers
published 18 May 2023
Loading metrics information...
Metrics unavailable. Please check back later.
-
ROS is a master regulator of in vitro matriptase activation
published 30 Jan 2023
Loading metrics information...
Metrics unavailable. Please check back later.
-
An experimental-mathematical approach to predict tumor cell growth as a function of glucose availability in breast cancer cell lines
published 13 Jul 2021
Loading metrics information...
Metrics unavailable. Please check back later.
-
Tamoxifen resistance alters sensitivity to 5-fluorouracil in a subset of estrogen receptor-positive breast cancer
published 08 Jun 2021
Loading metrics information...
Metrics unavailable. Please check back later.
-
eNEMAL, an enhancer RNA transcribed from a distal MALAT1 enhancer, promotes NEAT1 long isoform expression
published 21 May 2021
Loading metrics information...
Metrics unavailable. Please check back later.
-
Anti-CD19 CAR T cells potently redirected to kill solid tumor cells
published 18 Mar 2021
Loading metrics information...
Metrics unavailable. Please check back later.
-
HER2-intronic miR-4728-5p facilitates HER2 expression and accelerates cell proliferation and migration by targeting EBP1 in breast cancer
published 02 Feb 2021
Loading metrics information...
Metrics unavailable. Please check back later.
-
Preparation and characterization of antibody-drug conjugates acting on HER2-positive cancer cells
published 28 Sep 2020
Loading metrics information...
Metrics unavailable. Please check back later.
-
Trastuzumab effects depend on HER2 phosphorylation in HER2-negative breast cancer cell lines
published 25 Jun 2020
Loading metrics information...
Metrics unavailable. Please check back later.
-
Loss of STAT6 leads to anchorage-independent growth and trastuzumab resistance in HER2+ breast cancer cells
published 11 Jun 2020
Loading metrics information...
Metrics unavailable. Please check back later.
-
Analysis of HER2 genomic binding in breast cancer cells identifies a global role in direct gene regulation
published 20 Nov 2019
Loading metrics information...
Metrics unavailable. Please check back later.
Connect with Us